Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
840.00    11.00 (1.33%)
Bid:
839.00
Ask:
842.00
Spread: 3.00 (0.358%)
Market Cap: £793.16m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding - Replacement

19 Aug 2025 11:08

RNS Number : 9183V
Polar Capital Holdings PLC
19 August 2025
 

19 August 2025

 

The following amendments have been made to the Director/PDMR Shareholding announcement released on 15 August 2025 at 9:42am under RNS No 5227V.

 

The prices have been amended.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Polar Capital Holdings plc ("Polar Capital" or the "Company")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

The Company was notified on 13 August 2025 that Ms. Rachel Stynes purchased 1,801 ordinary shares of 2.5p each ("Ordinary Shares") following an automatic dividend reinvestment for her personal holding at an aggregated price of 486.55p per share. Following this transaction Ms. Stynes is interested in a total of 32,033 Ordinary Shares representing 0.03% of the Company's issued share capital.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Stynes

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Human Resources

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Polar Capital Holdings plc

b)

 

LEI

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

Identification code

GB00B1GCLT25

b)

 

Nature of the transaction

 

Acquisition following dividend reinvestment

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

487.59 pence per share

980

485.50 pence per share

821

d)

 

Aggregated information

as in 4 c) above

- Aggregated volume

1801

- Price

486.55 pence per share

 

e)

 

Date of the transaction

 

13/08/2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

Samir Ayub (CFO)

 

Deutsche Numis - Nomad and Joint Broker +44 (0)20 7260 1000

Giles Rolls (QE)

Charles Farquhar

 

Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680

Andrew Buchanan

Sam Milford

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEPNFELSEFA
Date   Source Headline
15th Jul 202411:04 amRNSDirector/PDMR Shareholding
11th Jul 20249:49 amRNSForm 8.3 - CREST NICHOLSON HOLDINGS PLC
11th Jul 20247:00 amRNSAuM Update
4th Jul 20246:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20245:05 pmRNSHolding(s) in Company
27th Jun 20241:15 pmRNSGroup Audited Results for year ended 31 March 2024
27th Jun 20247:00 amRNSGroup Audited Results for year ended 31 March 2024
17th Jun 20243:37 pmRNSForm 8.3 - CREST NICHOLSON HOLDINGS
3rd Jun 20246:16 pmRNSTotal Voting Rights
3rd Jun 20241:56 pmRNSTotal Voting Rights
22nd May 20249:12 amRNSIssue of Equity
15th May 202410:06 amRNSDirector/PDMR Shareholding
13th May 20245:49 pmRNSHolding(s) in Company
13th May 20243:34 pmRNSHolding(s) in Company
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.